Exagen Financial Overview
Exagen's market cap is currently $143.23M. The company's EPS TTM is $-0.31; its P/E ratio is ―; Exagen is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
